PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Ford ([[F]] +0.8%) says new plants in Asia will be able to manufacture up to 7 different models as its adds flexibility to its factories in the region. The automaker could see the Asia Pacific Africa region contribute close to a third of all its…

Category : Stocks

Ford (F +0.8%) says new plants in Asia will be able to manufacture up to 7 different models as its adds flexibility to its factories in the region. The automaker could see the Asia Pacific Africa region contribute close to a third of all its global sales by the middle of the decade. 3 comments!

View post: Ford ([[F]] +0.8%) says new plants in Asia will be able to manufacture up to 7 different models as its adds flexibility to its factories in the region. The automaker could see the Asia Pacific Africa region contribute close to a third of all its…

Post to Twitter

Legends Business Group, Inc. (LGBS: OTC Link) | LEGENDS EXECUTES AGREEMENT FOR MULTI-FUNCITION CHARGER CONTROLLER

Category : World News

Legends Business Group, Inc. announced exclusive rights to manufacture and distribute proprietary Multi-Function Charger Controller (MFCC)

Legends Business Group (LGBS: PK) today announced it has completed an agreement under which Legends has the exclusive rights to manufacture and distribute the Multi-Function Charge Controller (MFCC).

Under the terms of the agreement, Legends Business Group will have the rights to beta test, manufacture and distribute the MFCC in exchange for ten million shares of restricted common stock and a small percentage of gross revenue per unit. In addition to exercising its new rights, Legends has also agreed that it will make its’ best efforts to become a fully reporting Bulletin Board company by the end of the fourth reporting quarter of 2012.

“Since discovering the existence of the MFCC, Legends has been working along side of its creator to ensure this product became a reality,” said Rudy Sablon, LGBS’s President and CEO.

Post to Twitter

Sony and Panasonic in TV tie-up

Category : Business, World News

Electronic manufacturing giants Sony and Panasonic agree to join forces to manufacture panels for TVs and big displays.

More here: Sony and Panasonic in TV tie-up

Post to Twitter

UK Aerospace Parts Supplier, J.J. Churchill Ltd., Signs Agreement for Services in Mexico with The Offshore Group

Category : World News

British firm to manufacture aerospace parts in Guaymas, Sonora, Mexico.

Read more: UK Aerospace Parts Supplier, J.J. Churchill Ltd., Signs Agreement for Services in Mexico with The Offshore Group

Post to Twitter

More Than a Third of Large Manufacturers Are Considering Reshoring From China to the U.S.

Category : Stocks

Boston Consulting Group Survey Confirms That Rising Chinese Wages, Logistics, and Other Factors Are Prompting Companies to Rethink Where They Manufacture

Original post: More Than a Third of Large Manufacturers Are Considering Reshoring From China to the U.S.

Post to Twitter

Parker Aerospace Extends Contract for Support Services in Mexico with The Offshore Group

Category : World News

Aerospace manufacturer to continue to manufacture and assemble aerospace equipment in Mexico through 2017.

Read more here: Parker Aerospace Extends Contract for Support Services in Mexico with The Offshore Group

Post to Twitter

Mexico Manufacturing Facility Start-Up Process is the Subject of Offshore Group Podcast

Category : World News

The time it takes to begin to manufacture in Mexico varies depending on products and processes.

Continued here: Mexico Manufacturing Facility Start-Up Process is the Subject of Offshore Group Podcast

Post to Twitter

IKOR Industries Signs Contract for Manufacturing Support Services in Mexico with The Offshore Group

Category : World News

Company to manufacture electrical cables, harnesses and connectors in Mexico.

Continue reading here: IKOR Industries Signs Contract for Manufacturing Support Services in Mexico with The Offshore Group

Post to Twitter

China faces rare earth trade case

Category : World News

The US, EU and Japan file a landmark trade case against China over export of rare earths, which are critical to the manufacture of high-tech products.

See more here: China faces rare earth trade case

Post to Twitter

Cancer drug shortage crisis: ‘We have been burned before’

Category : Business

Betsy Neiser was being treated for advanced ovarian cancer with Doxil, a tumour-shrinking drug she thought she could take indefinitely – but then her doctor told her they had run out

Since Betsy Neiser, a lawyer and mother of two from Leverett, Massachusetts, was first diagnosed with advanced ovarian cancer in July 2002, she has had three recurrences, each successfully treated with chemotherapy.

After the last recurrence, in the summer of 2009, her cancer began to grow again, so she was put on Doxil, a mainstay chemo drug for recurrent ovarian cancer. Her tumour shrunk, the tumour markers reduced, her side effects were few and the expectation was that she could take it indefinitely.

But last July, when she went to hospital for her monthly infusion, the doctor had bad news. There were 12 patients waiting to be treated with Doxil, she was the second on the list and he only had one.

“I was scared. It’s comforting to know that I will get a drug on time when it will be most effective. When you don’t get it as part of a regular schedule the cancer starts growing.”

At first, she was told that there would be a three-week wait. Then, with no end to the Doxil shortage in sight, doctors put her on Adriamycin, a substitute. Neiser, 58, whose illness caused her to give up law and become a director of a community cancer support centre, said the effects were marked.

“I lost my hair for the third time. I became very nauseous for seven weeks. My fatigue levels were such that I could not go to work for long periods. I went on vacation to Michigan and slept for 18 hours a day.”

Worst of all, it affected her identity.

“When you have a metastatic cancer like ovarian cancer and you know you can never be cured, your quality of life becomes very important. When you are sick you feel defined by your illness. I define myself by how productive I am.”

Neiser found the experience so disturbing that she launched a grassroots campaign to tackle the drug shortage crisis.

She said: “I can’t complain. There are so many people who are so much more sick. I feel terrible for them, especially the children whose leukaemia is treatable with methotrexate.

“My doctors told me I would probably get more Doxil because of the patients who had died because they couldn’t get Doxil.”

The shortage was caused by Ben Venue Laboratories temporarily stopping production of the drug due to contamination issues and then choosing to halt production altogether.

Neiser said: “I’m thrilled the FDA have found more stores of Doxil, but it is temporary and we have been burned before. I’m disappointed that the distributor, Johnson & Johnson, only relied on one manufacture of the drug. A single manufacturer increased exponentially the risk of a shortage. They should have known that was an issue.

“There needs to be an improvement in the manufacture and distribution standards of drugs that cure a disease and prolong life. There’s a responsibility on the shoulders of regulators but also on the industry itself.”